Related Experiment Video
Updated: Sep 22, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database
Beom Joon Kim1, Arum Choi2, Hwan Soo Kim1
1Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Insights
The COVID-19 pandemic led to a 33% decrease in Kawasaki disease (KD) hospitalizations in Korea. While more infants were diagnosed with KD, clinical outcomes and cardiac complications remained unchanged.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiology
Background:
- The effect of the COVID-19 pandemic on Kawasaki disease (KD) incidence and severity is not well understood.
- This study examines changes in KD cases and associated coronary artery complications in Korea during the pandemic.
Purpose of the Study:
- To investigate the impact of the COVID-19 pandemic on the number and severity of Kawasaki disease cases.
- To analyze changes in cardiac complications among pediatric patients with KD during the pandemic.
Main Methods:
- Retrospective observational study of patients under 18 years old diagnosed with acute-phase KD from March 2018 to February 2021.
- Data collected from a Clinical Data Warehouse across five Korean university hospitals.
- Analysis of patient admissions and clinical characteristics, including cardiac complications, before and after the pandemic's onset.
Main Results:
- A 33% decrease in KD hospitalizations was observed after March 2020 compared to the preceding two years.
- Monthly admissions for KD significantly declined by 7.9 patients/month post-pandemic onset.
- The proportion of KD patients under one year old increased, while refractory KD and cardiac complication rates showed no significant changes.
Conclusions:
- The COVID-19 pandemic correlated with a reduced number of Kawasaki disease hospital admissions in Korea.
- Despite an increased proportion of infant admissions, the clinical course and complication rates for KD did not significantly alter during the pandemic.
Background:
The impact of the coronavirus disease 2019 (COVID-19) pandemic on Kawasaki disease (KD) has not yet been established. We investigated changes in the observed number and severity of KD cases and accompanying coronary artery complications during the COVID-19 pandemic in Korea.
Methods:
This retrospective observational study included patients aged < 18 years with acute-phase KD diagnosed between March 2018 and February 2021. Data were extracted from the Clinical Data Warehouse that houses data from five affiliated university hospitals in Korea. We analyzed changes in the number of patient admissions and clinical characteristics, including cardiac complications, before and after the onset of the COVID-19 pandemic.
Results:
A total of 475 admissions were included in the analysis. After March 2020, we observed a significant decrease of 33% in the number of hospitalizations for KD compared with the average number of hospitalizations during the previous 2 years. The number of admissions per month significantly decreased by 7.9 persons/month (95% confidence interval, -13.8 to -2.0; P < 0.05) compared with that before COVID-19. By contrast, the proportion of patients aged < 1 year with KD increased. The proportion of patients with refractory KD and the rate of cardiac complications did not change significantly.
Conclusion:
Since the onset of the COVID-19 pandemic, the total number of hospital admissions for KD has decreased in Korea. Although the proportion of admissions of infants aged < 1 year increased, no changes were observed in clinical courses and complications.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests